» Articles » PMID: 25015342

Cost-effectiveness of Follow-up of Pulmonary Nodules Incidentally Detected on Cardiac Computed Tomographic Angiography in Patients with Suspected Coronary Artery Disease

Overview
Journal Circulation
Date 2014 Jul 13
PMID 25015342
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary nodules (PNs) are often detected incidentally during coronary computed tomographic (CT) angiography, which is increasingly being used to evaluate patients with chest pain symptoms. However, the efficiency of following up on incidentally detected PN is unknown.

Methods And Results: We determined demographic and clinical characteristics of stable symptomatic patients referred for coronary CT angiography in whom incidentally detected PNs warranted follow-up. A validated lung cancer simulation model was populated with data from these patients, and clinical and economic consequences of follow-up per Fleischner guidelines versus no follow-up were simulated. Of the 3665 patients referred for coronary CT angiography, 591 (16%) had PNs requiring follow-up. The mean age of patients with PNs was 59±10 years; 66% were male; 67% had ever smoked; and 21% had obstructive coronary artery disease. The projected overall lung cancer incidence was 5.8% in these patients, but the majority died of coronary artery disease (38%) and other causes (57%). Follow-up of PNs was associated with a 4.6% relative reduction in cumulative lung cancer mortality (absolute mortality: follow-up, 4.33% versus non-follow-up, 4.54%), more downstream testing (follow-up, 2.34 CTs per patient versus non-follow-up, 1.01 CTs per patient), and an average increase in quality-adjusted life of 7 days. Costs per quality-adjusted life-year gained were $154 700 to follow up the entire cohort and $129 800 per quality-adjusted life-year when only smokers were included.

Conclusions: Follow-up of PNs incidentally detected in patients undergoing coronary CT angiography for chest pain evaluation is associated with a small reduction in lung cancer mortality. However, significant downstream testing contributes to limited efficiency, as demonstrated by a high cost per quality-adjusted life-year, especially in nonsmokers.

Citing Articles

Incidental pulmonary nodule management in Canada: exploring current state through a narrative literature review and expert interviews.

Digby G, Habert J, Sahota J, Zhu L, Manos D J Thorac Dis. 2024; 16(2):1537-1551.

PMID: 38505054 PMC: 10944736. DOI: 10.21037/jtd-23-1453.


The Cost Effectiveness of Coronary CT Angiography and the Effective Utilization of CT-Fractional Flow Reserve in the Diagnosis of Coronary Artery Disease.

Burch R, Siddiqui T, Tou L, Turner K, Umair M J Cardiovasc Dev Dis. 2023; 10(1).

PMID: 36661920 PMC: 9863924. DOI: 10.3390/jcdd10010025.


EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.

Duarte A, Corbett M, Melton H, Harden M, Palmer S, Soares M Health Technol Assess. 2022; 26(49):1-184.

PMID: 36534989 PMC: 9791464. DOI: 10.3310/IJFM4802.


The impact of cardiopulmonary hemodynamic factors in volumetry for pulmonary nodule management.

Guedes Pinto E, Penha D, Hochhegger B, Monaghan C, Marchiori E, Taborda-Barata L BMC Med Imaging. 2022; 22(1):49.

PMID: 35303820 PMC: 8932130. DOI: 10.1186/s12880-022-00774-w.


Incidental Findings of Malignancy of the Chest by Single Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT-CT MPI): One Year Follow-Up Report.

Tung R, Heyns J Kans J Med. 2020; 13:280-284.

PMID: 33312410 PMC: 7725129. DOI: 10.17161/kjm.vol13.13822.


References
1.
Tramontano A, Cipriano L, Kong C, Shepard J, Lanuti M, Gazelle G . Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol. 2013; 200(5):1020-7. PMC: 3722903. DOI: 10.2214/AJR.12.8968. View

2.
McMahon P, Kong C, Bouzan C, Weinstein M, Cipriano L, Tramontano A . Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011; 6(11):1841-8. PMC: 3202298. DOI: 10.1097/JTO.0b013e31822e59b3. View

3.
Ahn M, Gleeson T, Chan I, McWilliams A, Macdonald S, Lam S . Perifissural nodules seen at CT screening for lung cancer. Radiology. 2010; 254(3):949-56. DOI: 10.1148/radiol.09090031. View

4.
McMahon P, Kong C, Johnson B, Weinstein M, Weeks J, Tramontano A . Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012; 32 Suppl 1:S117-24. PMC: 3478757. DOI: 10.1111/j.1539-6924.2011.01652.x. View

5.
Min J, Dunning A, Lin F, Achenbach S, Al-Mallah M, Budoff M . Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International.... J Am Coll Cardiol. 2011; 58(8):849-60. DOI: 10.1016/j.jacc.2011.02.074. View